CONCLUSIONS: Imipenem/relebactam provides a new treatment option for infections caused by resistant gram-negative bacilli, including KPC-positive NME, MDR NME, and MDR P. aeruginosa.
Single-nucleotide polymorphisms in a vancomycin-resistant Staphylococcus aureus strain based on whole-genome sequencing.
Arch Microbiol. 2020 Jun 13;:
Authors: Kim JW, Lee KJ
Antifungal therapeutic drug monitoring: focus on drugs without a clear recommendation.
Clin Microbiol Infect. 2020 Jun 11;:
Authors: Gómez-López A
BACKGROUND: The goal of th…